Table 1.
Demographic and clinical data of study participants.
| Variable | Value |
|---|---|
| Number of participants | 586 |
| Age, years, mean (sd) | 67.3 (10.2) |
| Sex, n (%) | |
| Male | 401 (68.4) |
| Female | 183 (31.2) |
| Country of birth, n (%) | |
| Canada | 397 (67.7) |
| Outside of Canada | 183 (31.2) |
| Education, n (%) | |
| ≤Post‐secondary | 204 (34.8) |
| >Post‐secondary | 378 (64.5) |
| Residence setting, n (%) | |
| Urban | 319 (54.4) |
| Suburban | 166 (28.3) |
| Rural | 97 (16.6) |
| Time since diagnosis, n (%) | |
| 0–2 years ago | 75 (12.8) |
| 2–5 years ago | 288 (49.1) |
| 5+ years ago | 190 (32.4) |
| Disease type, n (%) | |
| MIBC | 137 (23.4) |
| NMIBC | 324 (55.3) |
| I do not know | 113 (19.3) |
| TNM staging, n (%) | |
| Ta, CIS, T1 | 324 (55.3) |
| T2–T4 | 129 (22.0) |
| N+, M+ | 8 (1.4) |
| I do not know | 113 (19.3) |
| Treatment, n (%) | |
| Surgery only | 170 (29.7) |
| Chemotherapy only | 16 (2.8) |
| Immunotherapy (BCG) | 33 (5.8) |
| Radiation only | 3 (0.5) |
| Surgery + chemotherapy | 108 (21.2) |
| Surgery + immunotherapy (BCG) | 261 (51.2) |
| Surgery + radiation | 35 (6.9) |
BCG, Bacillus Calmette– Guérin.